Page last updated: 2024-09-03

cholestyramine resin and acipimox

cholestyramine resin has been researched along with acipimox in 5 studies

Compound Research Comparison

Studies (cholestyramine resin)	Trials (cholestyramine resin)	Recent Studies (post-2010) (cholestyramine resin)	Studies (acipimox)	Trials (acipimox)	Recent Studies (post-2010) (acipimox)
2,669	342	190	283	140	50

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caslake, MJ; Gaw, A; Griffin, BA; Packard, CJ; Shepherd, J; Yip, B	1
Bedford, DK; Gaw, A; Kilday, C; Lorimer, AR; Packard, CJ; Series, JJ; Shepherd, J	1
Gylling, H; Miettinen, TA; Vanhanen, H	1
Celotti, F; de Paolis, C; Farina, R; Pianezzola, E; Pontiroli, AE; Valzelli, G	1
Collins, SM; Gaw, A; Lindsay, GM; Lorimer, AR; Packard, CJ; Shepherd, J	1

Trials

3 trial(s) available for cholestyramine resin and acipimox

Article	Year
Acipimox in combination with low dose cholestyramine for the treatment of type II hyperlipidaemia. British journal of clinical pharmacology, 1990, Volume: 30, Issue:1 Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoproteins; Patient Compliance; Pyrazines; Triglycerides	1990
Effects of acipimox and cholestyramine on serum lipoproteins, non-cholesterol sterols and cholesterol absorption and elimination. European journal of clinical pharmacology, 1989, Volume: 37, Issue:2 Topics: Adult; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Feces; Female; Humans; Hypolipidemic Agents; Intestinal Absorption; Lipids; Lipoproteins; Male; Phenotype; Pyrazines; Squalene; Sterols	1989
Lack of pharmacokinetic interaction between cholestyramine and acipimox, a new lipid lowering drug. British journal of clinical pharmacology, 1986, Volume: 22, Issue:4 Topics: Adult; Cholestyramine Resin; Clinical Trials as Topic; Drug Interactions; Humans; Hypolipidemic Agents; Kinetics; Pyrazines; Random Allocation	1986

Other Studies

2 other study(ies) available for cholestyramine resin and acipimox

Article	Year
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects. European journal of clinical investigation, 1992, Volume: 22, Issue:6 Topics: Adult; Centrifugation, Density Gradient; Cholestyramine Resin; Drug Therapy, Combination; Electrophoresis; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Reference Values	1992
Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy. European journal of medical research, 1995, Oct-16, Volume: 1, Issue:1 Topics: Adult; Apolipoproteins B; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Pyrazines	1995

Article

Year

Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects.

European journal of clinical investigation, 1992, Volume: 22, Issue:6

Topics: Adult; Centrifugation, Density Gradient; Cholestyramine Resin; Drug Therapy, Combination; Electrophoresis; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Reference Values

1992

Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy.

European journal of medical research, 1995, Oct-16, Volume: 1, Issue:1

Topics: Adult; Apolipoproteins B; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Pyrazines

1995